科华生物 (002022)
SHANGHAI KEHUA BIO-ENGINEERING CO.,LTD.
K-Line Chart
No K-line data available
Company NameShanghai Kehua Bio-engineering Co., Ltd.
Listing Date2004-07-21
Issue Price11.12RMB
Registered Capital51431.812110k RMB
Legal RepresentativeLi Ming
Registered AddressNo. 1189, Qinzhou North Road, Xuhui District, Shanghai
IndustryMedical Devices
Main BusinessResearch, production, and sales of in vitro clinical immuno-diagnostic reagents, in vitro clinical chemical diagnostic reagents, nucleic acid diagnostic reagents, genetically engineered drugs, and automated diagnostic instruments compatible with in vitro diagnostic reagents.
Company ProfileShanghai Kehua Bio-engineering Co., Ltd. was founded in 1981. It is the first professional diagnostic products company listed on the SME Board of the Shenzhen Stock Exchange in China. The company integrates product R&D, production, and sales, possessing a complete industrial chain in the medical diagnostics field. Its main business covers in vitro diagnostic reagents and medical testing instruments. As an R&D-driven high-tech enterprise, the company relies on its Biotechnology Innovation Center and Postdoctoral Research Station to establish two major R&D technology platforms for clinical in vitro diagnostic reagents and fully automated testing and analysis instruments. It is progressively advancing the development goals of "serialization" and "integration" for reagents and instruments.
Stock Details
1. Key Indicators
- Total Shares(W): 51434.82
- Circulating A-Shares(W): 51425.07
- Earnings Per Share(RMB): -0.4521
- Net Assets Per Share(RMB): 6.0277
- Operating Revenue(W RMB): 119126.06
- Total Profit(W RMB): -25175.38
- Net Profit Attributable to Parent(W RMB): -23253.28
- Net Profit Growth Rate(%): -90.38
- Weighted Return on Equity(%): -7.1600
- Operating Cash Flow Per Share(RMB): -0.0470
- Undistributed Profit Per Share(RMB): 4.2966
- Capital Reserve Per Share(RMB): 0.4451
2. Main Business
The main business covers:
- Research, production, and sales of in vitro diagnostic reagents
- Research, production, and sales of medical testing instruments
3. Company Basic Information
- Company Name: Shanghai Kehua Bioengineering Co., Ltd.
- Listing Date: 2004-07-21
- Industry: Pharmaceutical Manufacturing
- Address: No. 1189, Qinzhou North Road, Xuhui District, Shanghai
- Website: www.skhb.com
- Company Profile: The company was established as a joint-stock company by the initiators including the former Employee Shareholding Association of Shanghai Kehua Bioengineering Co., Ltd., Tang Weiguo, Sha Liwu, Xu Xiande, Shanghai Keshen Industrial Co., Ltd., and 47 other natural persons, approved by the Shanghai Municipal Government Document Hufu Tigaishan (1998) No. 065. The issuer was established on November 23, 1998, with a business registration number of 3100001005388, and the total share capital before issuance was 50.75 million shares.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Zhuhai Baolian Investment Holding Co., Ltd. | General Legal Person | 7014.72 | 13.64 |
| 2 | Xi'an Zhitong Benyi Enterprise Management Partnership (Limited Partnership) | General Legal Person | 2571.59 | 5.00 |
| 3 | Shanghai Puzhen Private Fund Management Co., Ltd. - Puzhen Ruoyu No. 2 Private Securities Investment Fund | Private Securities Investment Fund | 547.00 | 1.06 |
| 4 | Yongying CSI All Share Medical Devices Traded Open-End Index Securities Investment Fund | Fund | 317.32 | 0.62 |
5. Concept Sectors
- Convertible Bonds
- Biological Vaccines
- Gene Concept
- Hepatitis Concept
- Pet Economy
- Foreign Background
- Consecutive Losses
- Micro and Small Cap Stocks
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information